Proxy Biomedical Ltd. 04.28.17
Proxy Biomedical Ltd., provider of outsourced design, development and manufacturing services for implantable medical devices, has formed a new group company and brand, Aran Biomedical.
According to the company, the new corporate identity is part of an overall rebranding and restructuring strategy to position the company in line with the broader range of capabilities now servicing key growth markets of cardiovascular, general surgery and orthopedics.
Headquartered in Galway, Ireland, the company has been delivering solutions for medical implantable products for more than 15 years, servicing many Tier 1 medical devices companies globally. During this time, the company has invested significantly to establish a comprehensive suite of product development and manufacturing capabilities, including medical textiles, stent coating and encapsulation, and resorbable implants.
“The company has grown and diversified significantly from its origins, servicing the general surgery market,” CEO Peter Mulrooney said. “Establishing Aran Biomedical allows us to position the company to better reflect the breadth of solutions the company now offers for different markets and indications.”
This announcement follows a facility expansion and investment in state-of-the-art equipment that enhances medical textile, coating, and covering service offerings for the cardiovascular, general surgery, and orthopedics markets. Mulrooney said: “Leveraging new facilities and an advanced technology portfolio will enable us to meet and build on the demand that we are currently experiencing for biomaterial solutions to service the global implantable medical device market, and we look forward to continued growth under the new Aran Biomedical name.”
Aran Biomedical is an Irish company that specializes in customized medical implant product solutions, with expertise in medical textiles, stent coating and encapsulation, as well as resorbable implants. The company offers a full-service solution, from design and development, to full-scale manufacturing of key components and finished devices, for Tier 1 medical device companies.
According to the company, the new corporate identity is part of an overall rebranding and restructuring strategy to position the company in line with the broader range of capabilities now servicing key growth markets of cardiovascular, general surgery and orthopedics.
Headquartered in Galway, Ireland, the company has been delivering solutions for medical implantable products for more than 15 years, servicing many Tier 1 medical devices companies globally. During this time, the company has invested significantly to establish a comprehensive suite of product development and manufacturing capabilities, including medical textiles, stent coating and encapsulation, and resorbable implants.
“The company has grown and diversified significantly from its origins, servicing the general surgery market,” CEO Peter Mulrooney said. “Establishing Aran Biomedical allows us to position the company to better reflect the breadth of solutions the company now offers for different markets and indications.”
This announcement follows a facility expansion and investment in state-of-the-art equipment that enhances medical textile, coating, and covering service offerings for the cardiovascular, general surgery, and orthopedics markets. Mulrooney said: “Leveraging new facilities and an advanced technology portfolio will enable us to meet and build on the demand that we are currently experiencing for biomaterial solutions to service the global implantable medical device market, and we look forward to continued growth under the new Aran Biomedical name.”
Aran Biomedical is an Irish company that specializes in customized medical implant product solutions, with expertise in medical textiles, stent coating and encapsulation, as well as resorbable implants. The company offers a full-service solution, from design and development, to full-scale manufacturing of key components and finished devices, for Tier 1 medical device companies.